This year, our list of NEJM Journal Watch Oncology and Hematology top stories covers a broad range of trials in malignant hematology as well as breast, renal, colorectal, lung, and gastric cancers. These summaries underscore our goal of identifying the most clinically relevant studies and highlighting their key points, implications, and applications. We look forward to continuing to bring you concise summaries of the most important research in oncology and hematology during the coming year.
Our Oncology and Hematology Top 10 Stories of 2015 are:
Elotuzumab Effective for Multiple Myeloma
Curing Hodgkin Lymphoma Without Radiotherapy
Regional Nodal Irradiation for Early-Stage Breast Cancer
Gene-Expression Assay Prognostic in Breast Cancer
O…
Author
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)